ENCLEAR THERAPIES
EnClear Therapies is a Cambridge (USA) based life sciences company developing a device-based therapy to aid in the treatment of neurodegenerative disease and delivery and monitoring of cerebrospinal fluid (CSF). EnClear’s proprietary therapeutic platform focuses on removing toxic proteins from the CSF. The company’s first products will target improving the lives of patients with Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP).
ENCLEAR THERAPIES
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.encleartherapies.com
Total Employee:
1+
Status:
Active
Total Funding:
12 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business PHP Google Google Cloud
Similar Organizations
Alios BioPharma
Alios BioPharma is a biotechnology company developing novel medicines for the treatment of viral diseases.
Atalanta Therapeutics
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Convalesce
Stem Cell Based Therapy for Neurodegenerative diseases
Currus Biologics
Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Genascence
Clinical-stage biotechnology company developing life-changing gene therapy products for musculoskeletal diseases
Ray Therapeutics
Ray Therapeutics is a biotech company developing optogenetic gene therapies for patients with blinding diseases.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Stalicla
STALICLA is a biotechnology company developing precision medicine treatments for patients with neurodevelopmental disorders.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Dolby Family Ventures
Dolby Family Ventures investment in Series A - EnClear Therapies
Quark Venture
Quark Venture investment in Series A - EnClear Therapies
Amgen Ventures
Amgen Ventures investment in Series A - EnClear Therapies
Tachyon Ventures
Tachyon Ventures investment in Series A - EnClear Therapies
Presight Capital
Presight Capital investment in Series A - EnClear Therapies
20/20 HealthCare Partners
20/20 HealthCare Partners investment in Series A - EnClear Therapies
Thiel Capital
Thiel Capital investment in Series A - EnClear Therapies
Peter Thiel
Peter Thiel investment in Series A - EnClear Therapies
Bioverge
Bioverge investment in Series A - EnClear Therapies
Global health sciences venture fund
Global health sciences venture fund investment in Series A - EnClear Therapies
Official Site Inspections
http://www.encleartherapies.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "EnClear Therapies"
About Us - EnClear Therapies
Our mission is to extend the lives of patients with CNS-related disease.. Our opportunity is to utilize CSF for controlled, continuous, & personalized delivery to areas of the CNS most benefited by both existing & next-generation …See details»
EnClear Therapies - Crunchbase Company Profile
EnClear Therapies is a Cambridge (USA) based life sciences company developing a device-based therapy to aid in the treatment of …See details»
EnClear Therapies - LinkedIn
Now presenting at #InnovationSanDiego is EnClear Therapies with Co-Founder & CEO Anthony DePasqua.EnClear Therapies, Inc. (Cambridge, MA, USA) incorporated in Delaware, 2018 as a spin out of ...See details»
EnClear Therapies Company Profile | Management and Employees …
[email protected]: EnClear Therapies Top Competitors. Company Employees Revenue Top technologies; Tranquis Therapeutics Inc. 16: $1.2 M: Q Therapeutics Inc. 12: …See details»
EnClear Therapies Company Overview, Contact Details
EnClear Therapies received financing of $10M in Series A on Feb 19th '20. EnClear Therapies, a life sciences company developing device-based therapies for the treatment of …See details»
Enclear Therapies, Inc.: Drug pipelines, Patents, Clinical trials
Aug 17, 2023 Explore Enclear Therapies, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
EnClear Therapies - Craft
EnClear Therapies is a company that develops a medical device designed for the treatment of neurological diseases. Its neurology-focused device-based systems remove toxic proteins as …See details»
Enclear Therapies, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Enclear Therapies, Inc. of Newburyport, MA. Get the latest business insights from Dun & Bradstreet.See details»
EnClear Therapies - VentureRadar
At Enclear Therapies, our mission is to improve and extend the lives of genetically defined populations of patients suffering from neurodegenerative... ... Find out ...See details»
EnClear Therapies - PitchBook
EnClear Therapies General Information Description. Developer of device-based therapies designed to treat neurological diseases. The company's neurology-focused device-based …See details»
Advisors & Collaborators | EnClear Therapies
CEO and co-founder of QurAlis Corporation and is also co-founder and serves on the Board of Directors of EnClear Therapies. Kasper is a passionate neuroscientist and patient advocateSee details»
EnClear Therapies - Overview, News & Similar companies
Feb 19, 2020 EnClear Therapies contact info: Phone number: (603) 343-8504 Website: www.encleartherapies.com What does EnClear Therapies do? EnClear Therapies is a medical …See details»
EnClear Therapies, Inc. Secures Additional Funding to ... - BioSpace
Sep 4, 2024 Email: [email protected]. SOURCE: EnClear Therapies, Inc. View the original press release on accesswire.com. Twitter; LinkedIn; Facebook; Email Print …See details»
CSF Health Platform - EnClear Therapies
EnClear's EnTrega CSF Platform has been shown to deliver therapeutic levels to all regions of the brain, including deeper regions, in higher concentrations than standard of care.See details»
Medical Device Developer EnClear Spins out of QurAlis
Dec 27, 2018 Our mission is to halt the progression of disease and extend the lives of patients with Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP) by …See details»
Contact | EnClear Therapies
[email protected]. Name. Email. Subject. Message. Submit. Thanks for submitting! Contact: Get in Touch ©2021 by EnClear Therapies. bottom of page ...See details»
EnClear Therapies Raises $10 Million to Develop a Means to Filter ...
Feb 20, 2020 Leucadia Therapeutics and EnClear Therapies are both testing the hypothesis that clearance of molecular waste from cerebrospinal fluid is a viable form of prevention and …See details»
The EnClear Team | EnClear Therapies
Bringing together a highly experienced, multidisciplinary bio/med-tech team with a proven track record of successful platform & commercial market development.See details»
Programs - EnClear Therapies
Leptomeningeal carcinomatosis is typically a late complication with cancer that has poor prognosis and limited treatment options. Patients diagnosed with LC, without treatment, …See details»